kisunla

Generic: donanemab-azbt

Labeler: eli lilly and company
NDC Directory HUMAN PRESCRIPTION DRUG BLA Inactive Finished

Drug Facts

Product Profile

Brand Name kisunla
Generic Name donanemab-azbt
Labeler eli lilly and company
Dosage Form INJECTION, SOLUTION
Routes
INTRAVENOUS
Active Ingredients

donanemab 17.5 mg/mL

Manufacturer
Eli Lilly and Company

Identifiers & Regulatory

Product NDC 0002-9401
Product ID 0002-9401_85d3d68b-57f9-45e6-a1a7-fa19bc843f33
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category BLA
Application Number BLA761248
Listing Expiration 2026-12-31
Marketing Start 2024-07-02

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 00029401
Hyphenated Format 0002-9401

Supplemental Identifiers

RxCUI
2687972 2687979
UPC
0300029401018
UNII
1ADB65P1KK

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name kisunla (source: ndc)
Generic Name donanemab-azbt (source: ndc)
Application Number BLA761248 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 17.5 mg/mL
source: ndc
Packaging
  • 1 VIAL, SINGLE-DOSE in 1 CARTON (0002-9401-01) / 20 mL in 1 VIAL, SINGLE-DOSE
source: ndc

Packages (1)

0002-9401-01 1 VIAL, SINGLE-DOSE in 1 CARTON (0002-9401-01) / 20 mL in 1 VIAL, SINGLE-DOSE

Ingredients (1)

donanemab (17.5 mg/mL)

Linked Drug Pages (1)

Kisunla ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "85d3d68b-57f9-45e6-a1a7-fa19bc843f33", "openfda": {"upc": ["0300029401018"], "unii": ["1ADB65P1KK"], "rxcui": ["2687972", "2687979"], "spl_set_id": ["190352d4-ef62-4679-b4fa-e846e2766afa"], "manufacturer_name": ["Eli Lilly and Company"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (0002-9401-01)  / 20 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "0002-9401-01", "marketing_start_date": "20240702"}], "brand_name": "Kisunla", "product_id": "0002-9401_85d3d68b-57f9-45e6-a1a7-fa19bc843f33", "dosage_form": "INJECTION, SOLUTION", "product_ndc": "0002-9401", "generic_name": "donanemab-azbt", "labeler_name": "Eli Lilly and Company", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Kisunla", "active_ingredients": [{"name": "DONANEMAB", "strength": "17.5 mg/mL"}], "application_number": "BLA761248", "marketing_category": "BLA", "marketing_start_date": "20240702", "listing_expiration_date": "20261231"}